Free Trial

Merck & Co., Inc. (MRK) Earnings Date, Estimates & Call Transcripts

Merck & Co., Inc. logo
$76.74 -2.00 (-2.54%)
As of 09:40 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Merck & Co., Inc. Earnings Summary

Latest Q1
Earnings Date
Apr. 24Estimated
Consensus EPS
(Apr. 24)
$2.16
Actual EPS
(Apr. 24)
$2.22 Beat By $0.06

Merck & Co., Inc. posted Q1 2025 earnings on April 24, 2025, reporting an EPS of $2.22, which beat analysts' consensus estimates of $2.16 by $0.06. With a trailing EPS of $6.73 and a P/E Ratio of 11.70, Merck & Co., Inc.'s earnings are expected to grow 9.88% next year, from $9.01 to $9.90 per share.

Q1 2025 Earnings Resources

Get Merck & Co., Inc. Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck & Co., Inc. and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MRK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Merck & Co., Inc. Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$2.17$2.19$2.18 
Q2 20252$2.14$2.19$2.17 
Q3 20252$2.42$2.44$2.43 
Q4 20252$2.17$2.29$2.23 
FY 20258$8.90$9.11$9.01 
Q1 20262$2.26$2.29$2.28 
Q2 20262$2.24$2.29$2.27 
Q3 20262$2.41$2.63$2.52 
Q4 20262$2.34$2.39$2.37 
FY 20268$9.25$9.60$9.43 
Q1 20271$2.45$2.45$2.45 

Merck & Co., Inc. Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/24/2025Q1 2025$2.16$2.22+$0.06$2.01$15.59B-
2/4/2025Q4 2024$1.85$1.72 -$0.13$1.48$15.51B$15.62B
10/31/2024Q3 2024$1.50$1.57+$0.07$1.90$16.47B$16.66B
7/30/2024Q2 2024$2.16$2.28+$0.12$2.42$15.87B$16.10B
4/25/2024Q1 2024$1.94$2.07+$0.13$2.27$15.21B$15.78B
2/1/2024Q4 2023-$0.09$0.03+$0.12$0.54$14.49B$14.63B
10/26/2023Q3 2023$1.94$2.13+$0.19$2.40$15.30B$16.00B
8/1/2023Q2 2023-$2.18-$2.06+$0.12-$1.77$14.44B$15.04B
4/27/2023Q1 2023$1.34$1.40+$0.06$1.69$13.81B$14.49B

Merck & Co., Inc. Earnings - Frequently Asked Questions

Merck & Co., Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 24th, 2025 based off last year's report dates. Learn more on MRK's earnings history.

Merck & Co., Inc. issued an update on its FY25 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of $8.88 to $9.03 for the period, compared to the consensus earnings per share estimate of $9.13. The company issued revenue guidance of $64.1 billion to $65.6 billion, compared to the consensus revenue estimate of $67.07 billion.

In the previous quarter, Merck & Co., Inc. (NYSE:MRK) missed the analysts' consensus estimate of $1.85 by $0.13 with a reported earnings per share (EPS) of $1.72. Learn more on analysts' earnings estimate vs. MRK's actual earnings.

The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online.
Read Transcript

Merck & Co., Inc. (NYSE:MRK) has a recorded annual revenue of $64.17 billion.

Merck & Co., Inc. (NYSE:MRK) has a recorded net income of $17.12 billion. MRK has generated $6.73 earnings per share over the last four quarters.

Merck & Co., Inc. (NYSE:MRK) has a trailing price-to-earnings ratio of 11.70 and a forward price-to-earnings ratio of 8.74. The price/earnings-to-growth ratio is 0.77.

Merck & Co., Inc.'s earnings are expected to grow from $9.01 per share to $9.90 per share in the next year, which is a 9.88% increase.

More Earnings Resources from MarketBeat



This page (NYSE:MRK) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners